Medications for Breast Carcinoma

3 results

  • enhertu - fam - trastuzumab deruxtecan - nxki injection, powder, lyophilized, for solution

    (Fam-Trastuzumab Deruxtecan-Nxki)
    Daiichi Sankyo Inc.
    ENHERTU treats HER2-positive and HER2-low/ultralow unresectable or metastatic breast cancer in adults, HER2-mutant non-small cell lung cancer, HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, and HER2-positive (IHC 3+) unresectable or metastatic solid tumors with no satisfactory alternatives.
    Medication Details
    Drug Interactions

  • trazimera - trastuzumab - qyyp

    (Trastuzumab-Qyyp)
    Pfizer Laboratories Div Pfizer Inc
    Trazimera treats HER2-overexpressing breast cancer in adults, including adjuvant node-positive or high-risk node-negative disease, first-line metastatic breast cancer (with paclitaxel), and single-agent use after prior chemotherapy. Also indicated for HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma with cisplatin and capecitabine or 5-fluorouracil.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • zoladex - goserelin implant

    (Goserelin)
    Tersera Therapeutics Llc
    Zoladex treats locally confined and advanced prostate carcinoma, endometriosis, and advanced breast cancer in pre- and perimenopausal women. Also used as an endometrial-thinning agent before ablation for dysfunctional uterine bleeding.
    Medication Details
    Drug Interactions